U.S. flag

An official website of the United States government

NM_006296.7(VRK2):c.*102_*105dup AND Fanconi anemia

Germline classification:
Conflicting interpretations of pathogenicity (3 submissions)
Last evaluated:
Jan 31, 2024
Review status:
criteria provided, conflicting classifications
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000226300.21

Allele description

NM_006296.7(VRK2):c.*102_*105dup

Genes:
FANCL:FA complementation group L [Gene - OMIM - HGNC]
VRK2:VRK serine/threonine kinase 2 [Gene - OMIM - HGNC]
Variant type:
Duplication
Cytogenetic location:
2p16.1
Genomic location:
Preferred name:
NM_006296.7(VRK2):c.*102_*105dup
HGVS:
  • NC_000002.11:g.58386929_58386932dup
  • NC_000002.12:g.58159795_58159798dup
  • NG_007418.1:g.86583_86586dup
  • NG_029717.2:g.257055_257058dup
  • NM_001114636.2:c.1110_1113dup
  • NM_001130480.2:c.*102_*105dup
  • NM_001130481.2:c.*102_*105dup
  • NM_001130482.2:c.*102_*105dup
  • NM_001130483.2:c.*487_*490dup
  • NM_001288836.1:c.*102_*105dup
  • NM_001288837.2:c.*102_*105dup
  • NM_001288838.2:c.*487_*490dup
  • NM_001288839.2:c.*102_*105dup
  • NM_001374615.1:c.1141_1144dup
  • NM_001410792.1:c.1156_1159dup
  • NM_006296.7:c.*102_*105dupMANE SELECT
  • NM_018062.4:c.1096_1099dupMANE SELECT
  • NP_001108108.1:p.Thr372Asnfs
  • NP_001108108.1:p.Thr372fs
  • NP_001361544.1:p.Thr382fs
  • NP_001397721.1:p.Thr387fs
  • NP_060532.2:p.Thr367Asnfs
  • NP_060532.2:p.Thr367fs
  • LRG_501t1:c.1111_1114dup
  • LRG_501t2:c.1095_1098dup
  • LRG_501:g.86583_86586dup
  • LRG_501p1:p.Thr372fs
  • LRG_501p2:p.Thr367Asnfs
  • NC_000002.11:g.58386928_58386929insTAAT
  • NC_000002.11:g.58386929_58386932dup
  • NC_000002.11:g.58386930_58386933dup
  • NM_001114636.1:c.1111_1114dup
  • NM_001114636.1:c.1111_1114dupATTA
  • NM_018062.3:c.1095_1098dup
  • NM_018062.3:c.1096_1099dupATTA
  • NM_018062.4:c.1096_1099dup
  • NR_156742.1:n.885_888dup
  • NR_156742.2:n.829_832dup
  • NR_164659.1:n.977_980dup
  • NR_164659.2:n.994_997dup
Protein change:
T367fs
Links:
LOVD 3: FANCL_000003; OMIM: 608111.0003; dbSNP: rs759217526
NCBI 1000 Genomes Browser:
rs759217526
Molecular consequence:
  • NM_001130480.2:c.*102_*105dup - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
  • NM_001130481.2:c.*102_*105dup - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
  • NM_001130482.2:c.*102_*105dup - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
  • NM_001130483.2:c.*487_*490dup - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
  • NM_001288836.1:c.*102_*105dup - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
  • NM_001288837.2:c.*102_*105dup - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
  • NM_001288838.2:c.*487_*490dup - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
  • NM_001288839.2:c.*102_*105dup - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
  • NM_006296.7:c.*102_*105dup - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
  • NM_001114636.2:c.1110_1113dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001374615.1:c.1141_1144dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001410792.1:c.1156_1159dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_018062.4:c.1096_1099dup - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
Fanconi anemia (FA)
Synonyms:
Fanconi pancytopenia; Fanconi's anemia
Identifiers:
MONDO: MONDO:0019391; MeSH: D005199; MedGen: C0015625; Orphanet: 84; OMIM: PS227650

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000290416Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Benign
(Jan 31, 2024)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV000431329Illumina Laboratory Services, Illumina
criteria provided, single submitter

(ICSL Variant Classification 20161018)
Uncertain significance
(Jun 14, 2016)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

ICSL_Variant_Classification_20161018.pdf,

Citation Link,

SCV002527272Sema4, Sema4
criteria provided, single submitter

(Sema4 Curation Guidelines)
Likely benign
(Jun 4, 2021)
germlinecuration

PubMed (9)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing, curation

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Mutations in Fanconi anemia genes and the risk of esophageal cancer.

Akbari MR, Malekzadeh R, Lepage P, Roquis D, Sadjadi AR, Aghcheli K, Yazdanbod A, Shakeri R, Bashiri J, Sotoudeh M, Pourshams A, Ghadirian P, Narod SA.

Hum Genet. 2011 May;129(5):573-82. doi: 10.1007/s00439-011-0951-7. Epub 2011 Jan 30.

PubMed [citation]
PMID:
21279724
See all PubMed Citations (10)

Details of each submission

From Invitae, SCV000290416.10

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Illumina Laboratory Services, Illumina, SCV000431329.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

The c.1111_1114dupATTA (p.Thr372AsnfsTer13) variant, which results in a frameshift near the C-terminus of the protein and extends the full-length protein by ten amino acids, was observed in a patient with clinical features suggestive of Fanconi anemia (Ali et al. 2009). This patient was compound heterozygous for the p.Thr372AsnfsTer13 variant, which was inherited from the patient's father, and a second inframe deletion variant that was inherited from the patient's mother. Functional testing of this variant, when ectopically expressed in FA-L patient cell line, resulted in a phenotype intermediate of EUFA868 cells expressing vector alone and EUFA868 cells expressing wild-type FANCL. The p.Thr372AsnfsTer13 variant has been reported at a frequency of 0.00783 in the population described as 'Other' in the Exome Aggregation Consortium. The evidence for this variant is limited. Based on the evidence from the literature and due to the potential impact of frameshift variants, the p.Thr372AsnfsTer13 variant is classified as a variant of uncertain significance but suspicious for pathogenicity for Fanconi anemia.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Sema4, Sema4, SCV002527272.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcuration PubMed (9)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 1, 2024